Acne drug can relieve stroke damage

Wolfson Center makes important breakthrough on widely used antibiotic.

October 4, 2007 23:10
1 minute read.
Acne drug can relieve stroke damage

pills 88. (photo credit: )


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Giving a stroke victim minocycline - a common antibiotic used to treat acne and other skin infections - within 24 hours of a stroke significantly reduces the brain damage caused to the patient, according to researchers at Wolfson Medical Center in Holon. Dr. Yair Lempel and colleagues, who published their discovery this week in the prestigious journal Neurology, said it was a breakthrough, as the antibiotic is widely used and its safety record is known. However, more research is needed to determine the exact dose that has the optimal effect on stroke patients and when to give it. Lempel, who is chairman of neurology at the hospital, said that the critical "window" after a stroke - in which oxygen-rich blood is prevented from reaching brain tissue - is the first three hours. This is when damage is most significant. The team gave minocyline to 74 patients within 24 hours of the stroke and compared the effects on 77 stroke patients who did not receive the antibiotic. Those who received the drug improved significantly compared to the control group, and there were no significant side effects in any who received minocycline. Minocycline hydrochloride, also known as minocycline, is a member of the broad spectrum tetracycline antibiotics and has a broader spectrum than the other members. It is a bacteriostatic antibiotic with a long half-life. Minocycline was originally discovered by Lederle Laboratories. Wolfson director-general Dr. Yitzhak Berlovich said he was proud of the professional work of the researchers and of their accomplishment. "This is another step in the program to establish a multidisciplinary center for treatment of stroke at Wolfson," he said.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia


Cookie Settings